Search Results - "Oyen, W"

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer by Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J.H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., Ciardiello, F., D'Hoore, A., Diaz-Rubio, E., Douillard, J.-Y., Ducreux, M., Falcone, A., Grothey, A., Gruenberger, T., Haustermans, K., Heinemann, V., Hoff, P., Köhne, C.-H., Labianca, R., Laurent-Puig, P., Ma, B., Maughan, T., Muro, K., Normanno, N., Österlund, P., Oyen, W.J.G., Papamichael, D., Pentheroudakis, G., Pfeiffer, P., Price, T.J., Punt, C., Ricke, J., Roth, A., Salazar, R., Scheithauer, W., Schmoll, H.J., Tabernero, J., Taïeb, J., Tejpar, S., Wasan, H., Yoshino, T., Zaanan, A., Arnold, D.

“…Colorectal cancer (CRC) is one of the most common malignancies in Western countries. Over the last 20 years, and the last decade in particular, the clinical…”
Get full text

Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial by Gebhart, G., Lamberts, L.E., Wimana, Z., Garcia, C., Emonts, P., Ameye, L., Stroobants, S., Huizing, M., Aftimos, P., Tol, J., Oyen, W.J.G., Vugts, D.J., Hoekstra, O.S., Schröder, C.P., Menke-van der Houven van Oordt, C.W., Guiot, T., Brouwers, A.H., Awada, A., de Vries, E.G.E., Flamen, P.

“…Only human epidermal growth factor receptor (HER)2 status determined by immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) has been…”
Get full text

Radiofrequency ablation for autonomously functioning nodules as treatment for hyperthyroidism: subgroup analysis of toxic adenoma and multinodular goitre and predictors for treatment success by van der Meeren, M. M. D., Joosten, F. B. M., Roerink, S. H. P. P., Deden, L. N., Oyen, W. J. G.

“…Purpose Treatment of hyperthyroidism caused by autonomously functioning thyroid nodules (AFTN) with 131 I often leads to undesirable hypothyroidism…”
Get full text

A systematic review on [18 F]FLT-PET uptake as a measure of treatment response in cancer patients by Bollineni, V.R, Kramer, G.M, Jansma, E.P, Liu, Y, Oyen, W.J.G

“…Abstract Imaging biomarkers have a potential to depict the hallmarks of cancers that characterise cancer cells as compared to normal cells. One pertinent…”
Get full text

Guidelines for radioiodine therapy of differentiated thyroid cancer by Luster, M., Clarke, S. E., Dietlein, M., Lassmann, M., Lind, P., Oyen, W. J. G., Tennvall, J., Bombardieri, E.

“…Introduction The purpose of the present guidelines on the radioiodine therapy (RAIT) of differentiated thyroid cancer (DTC) formulated by the European…”
Get full text

Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours by van der Graaf, W.T.A., Tesselaar, M.E.T., McVeigh, T.P., Oyen, W.J.G., Fröhling, S.

“…Rare cancers, which collectively account for almost 25 % of all malignancies, are poorly understood in terms of their aetiology and pathogenesis and are…”
Get full text

[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer by van Helden, E. J., Elias, S. G., Gerritse, S. L., van Es, S. C., Boon, E., Huisman, M. C., van Grieken, N. C. T., Dekker, H., van Dongen, G. A. M. S., Vugts, D. J., Boellaard, R., van Herpen, C. M. L., de Vries, E. G. E., Oyen, W. J. G., Brouwers, A. H., Verheul, H. M. W., Hoekstra, O. S., Menke-van der Houven van Oordt, C. W.

“…Purpose One-third of patients with RAS wild-type mCRC do not benefit from anti-EGFR monoclonal antibodies. This might be a result of variable pharmacokinetics…”
Get full text

Targeted Radionuclide and Fluorescence Dual-modality Imaging of Cancer: Preclinical Advances and Clinical Translation by Lütje, S., Rijpkema, M., Helfrich, W., Oyen, W. J. G., Boerman, O. C.

“…In oncology, sensitive and reliable detection tumor tissue is crucial to prevent recurrences and to improve surgical outcome. Currently, extensive research is…”
Get full text

Cost-Effectiveness of FDG-PET/CT for Cytologically Indeterminate Thyroid Nodules: A Decision Analytic Approach by Vriens, D, Adang, E. M. M, Netea-Maier, R. T, Smit, J. W. A, de Wilt, J. H. W, Oyen, W. J. G, de Geus-Oei, L. F

“…Context: Patients with thyroid nodules of indeterminate cytology undergo diagnostic surgery according to current guidelines. In 75% of patients, the nodule is…”
Get full text

FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome by Di Fonzo, A, Dekker, M C J, Montagna, P, Baruzzi, A, Yonova, E H, Correia Guedes, L, Szczerbinska, A, Zhao, T, Dubbel-Hulsman, L O M, Wouters, C H, de Graaff, E, Oyen, W J G, Simons, E J, Breedveld, G J, Oostra, B A, Horstink, M W, Bonifati, V

“…The combination of early-onset, progressive parkinsonism with pyramidal tract signs has been known as pallido-pyramidal or parkinsonian-pyramidal syndrome…”
Get full text

Anti-CEA Antibody Fragments Labeled with [18F]AlF for PET Imaging of CEA-Expressing Tumors by Lütje, S, Franssen, G. M, Sharkey, R. M, Laverman, P, Rossi, E. A, Goldenberg, D. M, Oyen, W. J. G, Boerman, O. C, McBride, W. J

“…A facile and rapid method to label peptides with 18F based on chelation of [18F]AlF has been developed recently. Since this method requires heating to 100 °C,…”
Get full text

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees by Horwich, A., Babjuk, M., Bellmunt, J., Bruins, H.M., De Reijke, T.M., De Santis, M., Gillessen, S., Maclennan, S., Palou, J., Powles, T., Van Der Kwast, T., Agarwal, N., Bamias, A., Birtle, A., Black, P.C., Bochner, B.H., Bolla, M., Boormans, J.L., Bossi, A., Brummelhuis, I., Burger, M., Castellano, D., Cathomas, R., Chiti, A., Choudhury, A., Compérat, E., Crabb, S., De Bari, B., DeBlok, W., De Visschere, P.J.L., Decaestecker, K., Dimitropoulos, K., Dominguez-Escrig, J.L., Fanti, S., Fonteyne, V., Frydenberg, M., Futterer, J.J., Gakis, G., Geavlete, B., Gontero, P., Grubmüller, B., Hafeez, S., Hansel, D.E., Hartmann, A., Hayne, D., Henry, A.M., Hernandez, V., Herr, H., Herrmann, K., Huguet, J., Jereczek-Fossa, B.A., Jones, R., Kamat, A.M., Kiltie, A.E., Krege, S., Ladoire, S., Lara, P.C., Linares-Espinós, E., Løgager, V., Lorch, A., Loriot, Y., Meijer, R., Carmen Mir, M., Moschini, M., Mostafid, H., Müller, A.-C., Müller, C.R., N’Dow, J., Necchi, A., Neuzillet, Y., Oldenburg, J., Pacheco-Figueiredo, L., Pappot, H., Patel, M.I., Pieters, B.R., Plass, K., Remzi, M., Rink, M., Roghmann, F., Rosenberg, J.E., Rouprêt, M., Rouvière, O., Salembier, C., Salminen, A., Sargos, P., Smeenk, R.J., Smits, A., Stenzl, A., Thalmann, G.N., Tombal, B., Vahr Lauridsen, S., Valdagni, R., Van Der Heijden, A.G., Vartolomei, M.D., Veskimäe, E., Vilaseca, A., Vives Rivera, F.A., Wiegel, T., Wiklund, P., Williams, A.

“…Although guidelines exist for advanced and variant bladder cancer management, evidence is limited/conflicting in some areas and the optimal approach remains…”
Get full text

Imaging angiogenesis in patients with head and neck squamous cell carcinomas by [68Ga]Ga-DOTA-E-[c(RGDfK)]2 PET/CT by Lobeek, D., Rijpkema, M., Terry, S. Y. A., Molkenboer-Kuenen, J. D. M., Joosten, L., van Genugten, E. A. J., van Engen-van Grunsven, A. C. H., Kaanders, J. H. A. M., Pegge, S. A. H., Boerman, O. C., Weijs, W. L. J., Merkx, M. A. W., van Herpen, C. M. L., Takes, R. P., Aarntzen, E. H. J. G., Oyen, W. J. G.

“…Purpose Angiogenesis plays an important role in the growth and metastatic spread of solid tumours and is characterised by the expression of integrins on the…”
Get full text

Ionising radiation exposure from medical imaging – A review of Patient's (un) awareness by Ribeiro, A., Husson, O., Drey, N., Murray, I., May, K., Thurston, J., Oyen, W.

“…Medical imaging is the main source of artificial radiation exposure. Evidence, however, suggests that patients are poorly informed about radiation exposure…”
Get full text

Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results by Schoffelen, R, Boerman, O C, Goldenberg, D M, Sharkey, R M, van Herpen, C M L, Franssen, G M, McBride, W J, Chang, C-H, Rossi, E A, van der Graaf, W T A, Oyen, W J G

“…Background: Radiolabelled antibody targeting of cancer is limited by slow blood clearance. Pretargeting with a non-radiolabelled bispecific monoclonal antibody…”
Get full text

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray" by Brans, B, Bodei, L, Giammarile, F, Linden, O, Luster, M, Oyen, W J G, Tennvall, J

“…Radionuclide therapy has distinct similarities to, but also profound differences from external radiotherapy. This review discusses techniques and results of…”
Get full text

Chemotherapy response evaluation with FDG–PET in patients with colorectal cancer by de Geus-Oei, L.F., van Laarhoven, H. W. M., Visser, E. P., Hermsen, R., van Hoorn, B. A., Kamm, Y. J. L., Krabbe, P. F. M., Corstens, F. H. M., Punt, C. J. A., Oyen, W. J. G.

“…Background: The aim of this prospective study was to evaluate the value of F-18-fluorodeoxyglucose–positron emission tomography (FDG–PET) for early assessment…”
Get full text

Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography by Wijsman, R, Kaanders, J H, Oyen, W J, Bussink, J

“…Due to the amazing leap of technology in radiation oncology in the past few years, cancer treatment will become more individualized. Molecular imaging with PET…”
Get full text

Beyond RECIST: Molecular and functional imaging techniques for evaluation of response to targeted therapy by Desar, I.M.E, van Herpen, C.M.L, van Laarhoven, H.W.M, Barentsz, J.O, Oyen, W.J.G, van der Graaf, W.T.A

“…Summary The development of targeted therapies is a major breakthrough in the treatment of cancer. By evoking necrosis and cavitation, evaluation based on…”
Get full text

Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise by Kouijzer, I.J.E., van der Meer, J.W.M., Oyen, W.J.G., Bleeker-Rovers, C.P.

Get full text